|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/5383 | (2006.01) |
| A61P 5/24 | (2006.01) | ||
| A61P 43/00 | (2006.01) |
| (11) | Number of the document | 3297631 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16723107.5 |
| Date of filing the European patent application | 2016-05-16 | |
| (97) | Date of publication of the European application | 2018-03-28 |
| (45) | Date of publication and mention of the grant of the patent | 2019-09-04 |
| (46) | Date of publication of the claims translation | 2019-10-25 |
| (86) | Number | PCT/EP2016/060945 |
| Date | 2016-05-16 |
| (87) | Number | WO 2016/184829 |
| Date | 2016-11-24 |
| (30) | Number | Date | Country code |
| 201562162870 P | 2015-05-18 | US |
| (72) |
TROWER, Mike, GB
|
| (73) |
KaNDy Therapeutics Limited,
400 South Oak Way, Reading, Berkshire, RG2 6AD,
GB
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | NK-1/NK-3 receptorių antagonistas, skirtas karščio pylimo gydymui |
| NK-1/NK-3 RECEPTOR ANTAGONIST FOR THE TREATMENT OF HOT FLUSHES |
| Payment date | Validity (years) | Amount | |
| 2025-04-22 | 10 | 231.00 EUR |
| 2026-05-16 |